VERGANI, BARBARA
VERGANI, BARBARA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
New Techniques:The Use of Fixed-Frozen Tissue in Routine Ultrastructural Evaluation and Immunogold Labeling
1992 Scopsi, L; Migliari, M; Vergani, B; Lombardi, L
Molecular abnormalities in liposarcoma: Role of MDM2 and CDK4-containing amplicons at 12q13-22
1998 Pilotti, S; Della Torre, G; Lavarino, C; Sozzi, G; Minoletti, F; Vergani, B; Azzarelli, A; Rilke, F; Pierotti, M
Morphologic-cytogenetic analysis of dedifferentiated liposarcomas with an extensive misleading leiomyosarcomatous component
2000 Pilotti, S; Mezzelani, A; Vergani, B; Minoletti, F; Cristofori, E; Sozzi, G; Pierotti, M
Two novel monoclonal antibodies against the MUC4 tandem repeat reacting with an antigen overexpressed by lung cancer
2000 Botti, C; Seregni, E; Menard, S; Collini, P; Tagliabue, E; Campiglio, M; Vergani, B; Ghirelli, C; Aiello, P; Pilotti, S; Bombardieri, E
Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors
2001 Birindelli, S; Perrone, F; Oggionni, M; Lavarino, C; Pasini, B; Vergani, B; Ranzani, G; Pierotti, M; Pilotti, S
Pulmonary resections: cytostructural effects of different-wavelength lasers versus electrocautery
2012 Scanagatta, P; Pelosi, G; Leo, F; Furia, S; Duranti, L; Fabbri, A; Manfrini, A; Villa, A; Vergani, B; Pastorino, U
Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma
2013 Castelli, C; Tazzari, M; Negri, T; Vergani, B; Rivoltini, L; Stacchiotti, S; Pilotti, S
Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class i peptides: Impact on the antigen-specific T cell response
2013 Camisaschi, C; Filipazzi, P; Tazzari, M; Casati, C; Beretta, V; Pilla, L; Patuzzo, R; Maurichi, A; Cova, A; Maio, M; Chiarion Sileni, V; Tragni, G; Santinami, M; Vergani, B; Villa, A; Berti, E; Umansky, L; Beckhove, P; Umansky, V; Parmiani, G; Rivoltini, L; Castelli, C
Alternative activation of human plasmacytoid DCs in vitro and in melanoma lesions: involvement of LAG-3
2014 Camisaschi, C; De Filippo, A; Beretta, V; Vergani, B; Villa, A; Vergani, E; Santinami, M; Cabras, A; Arienti, F; Triebel, F; Rodolfo, M; Rivoltini, L; Castelli, C
Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy
2014 Tazzari, M; Negri, T; Rini, F; Vergani, B; Huber, V; Villa, A; Dagrada, P; Colombo, C; Fiore, M; Gronchi, A; Stacchiotti, S; Casali, P; Pilotti, S; Rivoltini, L; Castelli, C
Null ABCA3 in humans: Large homozygous ABCA3 deletion, correlation to clinical-pathological findings
2014 Carrera, P; Ferrari, M; Presi, S; Ventura, L; Vergani, B; Lucchini, V; Cogo, P; Carnielli, V; Somaschini, M; Tagliabue, P
Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression
2014 Vallacchi, V; Vergani, E; Camisaschi, C; Deho, P; Cabras, A; Sensi, M; De Cecco, L; Bassani, N; Ambrogi, F; Carbone, A; Crippa, F; Vergani, B; Frati, P; Arienti, F; Patuzzo, R; Villa, A; Biganzoli, E; Canevari, S; Santinami, M; Castelli, C; Rivoltini, L; Rodolfo, M
Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: A case report
2015 Tazzari, M; Palassini, E; Vergani, B; Villa, A; Rini, F; Negri, T; Colombo, C; Crippa, F; Morosi, C; Casali, P; Pilotti, S; Stacchiotti, S; Rivoltini, L; Castelli, C
Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy
2015 Miglietta, D; De Palma, C; Sciorati, C; Vergani, B; Pisa, V; Villa, A; Ongini, E; Clementi, E
Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b
2016 Vergani, E; Di Guardo, L; Dugo, M; Rigoletto, S; Tragni, G; Ruggeri, R; Perrone, F; Tamborini, E; Gloghini, A; Arienti, F; Vergani, B; Deho, P; De Cecco, L; Vallacchi, V; Frati, P; Shahaj, E; Villa, A; Santinami, M; De Braud, F; Rivoltini, L; Rodolfo, M
TNF-related apoptosis-inducing ligand (trail)-armed exosomes deliver proapoptotic signals to tumor site
2016 Rivoltini, L; Chiodoni, C; Squarcina, P; Tortoreto, M; Villa, A; Vergani, B; Bürdek, M; Botti, L; Arioli, I; Cova, A; Mauri, G; Vergani, E; Bianchi, B; Della Mina, P; Cantone, L; Bollati, V; Zaffaroni, N; Gianni, A; Colombo, M; Huber, V
Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells
2016 Tuccitto, A; Tazzari, M; Beretta, V; Rini, F; Miranda, C; Greco, A; Santinami, M; Patuzzo, R; Vergani, B; Villa, A; Manenti, G; Cleris, L; Giardiello, D; Alison, M; Rivoltini, L; Castelli, C; Perego, M
Characterization of fast-twitch and slow-twitch skeletal muscles of calsequestrin 2 (CASQ2)-knock out mice: unexpected adaptive changes of fast-twitch muscles only
2016 Valle, G; Vergani, B; Sacchetto, R; Reggiani, C; De Rosa, E; Maccatrozzo, L; Nori, A; Villa, A; Volpe, P
Miaquant, a novel system for automatic segmentation, measurement, and localization comparison of different biomarkers from serialized histological slices
2017 Casiraghi, E; Cossa, M; Huber, V; Tozzi, M; Rivoltini, L; Villa, A; Vergani, B
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment
2017 Tazzari, M; Indio, V; Vergani, B; De Cecco, L; Rini, F; Negri, T; Camisaschi, C; Fiore, M; Stacchiotti, S; Dagrada, G; Casali, P; Gronchi, A; Astolfi, A; Pantaleo, M; Villa, A; Lombardo, C; Arienti, F; Pilotti, S; Rivoltini, L; Castelli, C